Login

Johan Ek, CEO, Handicare Group 00:00:00

Share On Facebook Share On Twitter

Handicare - Interview with CEO Johan Ek

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Driving Growth: A Comprehensive Analysis of Q4 2022 Performance | Jonas Gustavsson - President and CEO of AFRY
00:10:00
Decoding Market Dynamics: Mario Gabelli on Disney, Paramount, and the Future of Investing | Mario J. Gabelli, Chief Executive Officer , Gamco Investors Inc.
00:00:00
Daniel Lee Chief Executive Officer, Tissue Regenix Group
00:10:00
Milrock Resources: Pioneering Exploration Projects in Alaska and Mexico
00:10:00
A disciplined approach applying a consistent strategy|MARC VINAGRAY, Senior Associate,Pomona Capital
00:10:00
We invest in anything FAANG companies will buy or build|Ben Ling,General Partner, Bling Capital
00:10:00
Empowering Youth for a Sustainable Future: Insights from an Environmental Entrepreneur on Waste Valorization and Circular Thinking | Simona Grossi, CEO, Greenthesis Spa.
00:00:00
Dr Mariola Söhngen, CEO, Mologen
00:10:00
Tom Barrack on Real Estate Repricing, Digital Infrastructure, and the Presidential Election |Tom Barrack, Founder, Colony Capital.
00:10:00
Senior Advisor on Retirement Strategies at BlackRock
00:10:00
From Sports to Finance: Ted Virtue's Journey and Insights on Private Equity | Ted Virtue, CEO, MidOcean Partners.
00:10:00
Global Leaders in RNAi Therapeutics: Sirnaomics’ Commitment to Patient-Centered Care | Patrick Y. Lu , CEO, Sirnaomics Ltd.

© 2017 - Neuhu+